Aurobindo Pharma USA to acquire Lannett for $250 million, gets FTC approval
Aurobindo Pharma USA, Inc., a wholly owned subsidiary of Aurobindo Pharma Limited, received approval from the U.S. Federal Trade Commission on June 22, 2026 to proceed with its acquisition of